X @Bloomberg
Bloomberg·2026-02-20 00:56
Sumitomo Pharma shares declined after a Japanese government panel endorsed a conditional approval for its regenerative therapy, built on technology pioneered by a Nobel Prize laureate https://t.co/fEVqy6SmgN ...